Literature DB >> 3533682

Mechanism of abnormal oral glucose tolerance of genetically obese fa/fa rats.

F Rohner-Jeanrenaud, J Proietto, E Ionescu, B Jeanrenaud.   

Abstract

The genetically obese fa/fa rat is glucose intolerant when tested in a conscious state after the spontaneous ingestion of a glucose solution. The aim of this study was to investigate the mechanism(s) underlying the abnormal oral glucose tolerance test of obese animals with the non-steady-state measurement of glucose turnover proposed by Steele et al. in 1968. Our results show that the total rate of glucose appearance is enhanced in obese compared with lean animals. This abnormality is not due to an increased gut glucose absorption but to a lack of suppression and even a transient stimulation of hepatic glucose production after the ingestion of glucose. The rate of glucose utilization by the obese animals is somewhat increased compared with controls or unchanged when expressed as glucose metabolic clearance rate, thus excluding this parameter from the factors contributing to the observed glucose intolerance. The results obtained with genetically obese rats agree with those reported for type II diabetes in humans. The observed defect of the obese group could be related to an abnormal regulation of insulin counterregulatory hormone(s) or of hepatic innervation as well as to other defects of hepatic glycogen handling.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533682     DOI: 10.2337/diab.35.12.1350

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

Review 1.  Fuel selection and carbon flux during the starved-to-fed transition.

Authors:  M C Sugden; M J Holness; T N Palmer
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

2.  The onset of liver glycogen synthesis in fasted-refed lean and genetically obese (fa/fa) rats.

Authors:  G van de Werve; B Jeanrenaud
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

3.  Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.

Authors:  Christine Ahlström; Tobias Kroon; Lambertus A Peletier; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-10-10       Impact factor: 2.745

4.  Contribution of glycerol and alanine to basal hepatic glucose production in the genetically obese (fa/fa) rat.

Authors:  J Terrettaz; B Jeanrenaud
Journal:  Biochem J       Date:  1990-09-15       Impact factor: 3.857

5.  Initial glucose kinetics and hormonal response to a gastric glucose load in unrestrained post-absorptive and starved rats.

Authors:  C Smadja; J Morin; P Ferré; J Girard
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

6.  Oral vanadate decreases muscle insulin resistance in obese fa/fa rats.

Authors:  S M Brichard; L N Ongemba; J C Henquin
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

7.  Ocular complications in the old and glucose-intolerant genetically obese (fa/fa) rat.

Authors:  A Dosso; E Rungger-Brändle; F Rohner-Jeanrenaud; E Ionescu; C Guillaume-Gentil; B Jeanrenaud; P M Leuenberger
Journal:  Diabetologia       Date:  1990-03       Impact factor: 10.122

8.  Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.

Authors:  Kasi C McPherson; Lateia Taylor; Ashley C Johnson; Sean P Didion; Aron M Geurts; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27

9.  Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine.

Authors:  L Pénicaud; Y Hitier; P Ferré; J Girard
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

10.  Abnormal regulation of pancreatic glucagon secretion in obese fa/fa rats.

Authors:  F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.